Results 261 to 270 of about 823,617 (410)

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Long-term outcome of bone marrow transplantation in NIK deficiency: non-redundant role of non-canonical NF-κB signaling in thymic reconstitution and secondary lymphoid organ development. [PDF]

Front Immunol
Köstel Bal S, Haskoloğlu Ş, Ransmayr B, Sevinç S, İslamoğlu C, Baskın K, Deveci N, Savaş B, Fitoz S, Küpesiz A, Kendirli T, Boztug K, Doğu F, İkincioğulları KA.   +13 more
europepmc   +1 more source

Autologous Bone Marrow Transplantation.

Internal Medicine, 1996
openaire   +3 more sources

Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees.

Osteoarthritis and Cartilage, 2002
S. Wakitani, K. Imoto, Tetsuya Yamamoto, M. Saito, N. Murata, M. Yoneda   +5 more
semanticscholar   +1 more source

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source

A non-conditioned bone marrow transplantation mouse model to study clonal hematopoiesis and myeloid malignancies. [PDF]

Exp Hematol Oncol
Bentivegna S, Almosailleakh M, Zhao LP, Schuster MB, Benquet S, Balhuizen A, Munch-Petersen HF, Sjö LD, Andersen MH, Dulphy N, Porse B, Grønbæk K.   +11 more
europepmc   +1 more source

Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation.

Seminars in Oncology, 2012
L. Luznik, P. O'Donnell, E. Fuchs
semanticscholar   +1 more source

Diabetic stem-cell mobilopathy [PDF]

, 2011
DiPersio, John F
core   +2 more sources

Affinity Peptides With pH Sensitivity for the Enrichment of CD38+ Cells

Biotechnology and Bioengineering, EarlyView.
ABSTRACT The selective enrichment of cell populations based on surface markers is critical for the advancement of gene and cell therapies. Current antibody‐based cell isolation methods, such as fluorescence‐ and magnetic‐activated cell sorting (FACS and MACS), offer high specificity but are limited by scalability, cost, and potential adverse effects on
Gabrielle Rusch, Mickael Meyer, I. Mohamed Irfan, Carson Huber, Joseph Burclaff, Scott T. Magness, Stefano Menegatti, Michael Daniele   +7 more
wiley   +1 more source

Optimizing hematopoietic recovery following bone marrow transplantation

, 2002
Ronald Paquette, Kenneth Dorshkind
openalex   +1 more source